vyalev

Generic: foscarbidopa/foslevodopa

Labeler: abbvie inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vyalev
Generic Name foscarbidopa/foslevodopa
Labeler abbvie inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

foscarbidopa 12 mg/mL, foslevodopa 240 mg/mL

Manufacturer
AbbVie Inc.

Identifiers & Regulatory

Product NDC 0074-0501
Product ID 0074-0501_4c17adf8-afd2-43c7-8aca-59a2ca647f2a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216962
Listing Expiration 2026-12-31
Marketing Start 2022-04-12

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00740501
Hyphenated Format 0074-0501

Supplemental Identifiers

RxCUI
2695782 2695789
UNII
5NT8HCA4OO 37NQZ0J76I

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vyalev (source: ndc)
Generic Name foscarbidopa/foslevodopa (source: ndc)
Application Number NDA216962 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 12 mg/mL
  • 240 mg/mL
source: ndc
Packaging
  • 7 VIAL, SINGLE-DOSE in 1 CARTON (0074-0501-01) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (2)

foscarbidopa (12 mg/mL) foslevodopa (240 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "4c17adf8-afd2-43c7-8aca-59a2ca647f2a", "openfda": {"unii": ["5NT8HCA4OO", "37NQZ0J76I"], "rxcui": ["2695782", "2695789"], "spl_set_id": ["28e806e4-951c-40a9-9f0c-d0929caf054c"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 VIAL, SINGLE-DOSE in 1 CARTON (0074-0501-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0074-0501-01", "marketing_start_date": "20220412"}], "brand_name": "Vyalev", "product_id": "0074-0501_4c17adf8-afd2-43c7-8aca-59a2ca647f2a", "dosage_form": "INJECTION", "product_ndc": "0074-0501", "generic_name": "foscarbidopa/foslevodopa", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vyalev", "active_ingredients": [{"name": "FOSCARBIDOPA", "strength": "12 mg/mL"}, {"name": "FOSLEVODOPA", "strength": "240 mg/mL"}], "application_number": "NDA216962", "marketing_category": "NDA", "marketing_start_date": "20220412", "listing_expiration_date": "20261231"}